TY - CHAP M1 - Book, Section TI - Coagulation and Platelet Disorders A1 - Dushenkov, Anna A1 - Jungsuwadee, Paiboon A2 - Chisholm-Burns, Marie A. A2 - Schwinghammer, Terry L. A2 - Malone, Patrick M. A2 - Kolesar, Jill M. A2 - Bookstaver, P. Brandon A2 - Lee, Kelly C. PY - 2022 T2 - Pharmacotherapy Principles & Practice, 6e AB - LEARNING OBJECTIVESUpon completion of the chapter, the reader will be able to:Describe the basics of the regulation of hemostasis and thrombosis.Select appropriate nonpharmacological and pharmacological therapy for a patient with hemophilia in a given clinical situation.Calculate an appropriate factor-concentrate dose for a product, given the percentage correction desired based on clinical situation.List possible complications from hemophilia-induced bleeding episodes.Choose an appropriate treatment strategy for patients with factor VIII or IX inhibitors.Devise a treatment plan for a patient with a specific variant of von Willebrand disease (vWD).Describe various recessively inherited coagulation disorders (RICDs) and the role of specific factor replacement in RICD management.Recommend first-and second-line treatment approaches for immune thrombocytopenia (ITP).Identify basic clinical features, causes, and management of select thrombotic microangiopathies (TMAs). SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/09 UR - ppp.mhmedical.com/content.aspx?aid=1187026130 ER -